The future of
single-domain antibodies


We received many VHH nanobodies from Hybrigenics, selected and validated against Tau and phosho-Tau. The biochemical and functional characterization of those binders is ongoing but we can already say that this service opens new avenues for our research. — Dr. Luc Buée (Jean-Pierre Aubert Research Centre, Lille, France) - Europe

Back to testimonials

Back to Top